North America remains a dominant regional market for neuroendocrine carcinoma treatment owing to increasing cancer awareness, strong research and development capabilities, and widespread access to advanced healthcare services. The region benefits from a well-established regulatory framework, growing adoption of personalized medicine, and continuous advancements in cancer diagnostics and...

The global PET Scanners Market was valued at USD 2.04 billion in 2023 and is projected to reach USD 3.37 billion by 2030, expanding at a CAGR of 3.65% from 2024 to 2030. Market growth is primarily driven by continuous advancements in positron emission tomography (PET) imaging technology, increasing adoption of precision diagnostics, rising demand for radiopharmaceutical analysis, and...

The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...